{"transactions":[{"id":676416,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":20016,"kind":"person","name":"Tendler Craig","position":1,"cik":"0002061924","reported_name":"Tendler Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-25T22:14:33.000Z","date":"2026-08-22","kind":"grant","planned":false,"acquired":true,"shares":20294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments commencing from August 22, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":20294,"derivative":{"exercise_price":39.36,"expiration_date":"2036-08-21","underlying":"Common Stock","underlying_shares":20294},"source":{"system":"sec-edgar","filing":"0001193125-26-365484","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2061924/000119312526365484/ownership.xml","form_type":"4"}},{"id":901506,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":20016,"kind":"person","name":"Tendler Craig","position":1,"cik":"0002061924","reported_name":"Tendler Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2026-02-17T21:21:30.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":156240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents an annual option grant under the TuHURA Biosciences, Inc. 2024 Equity Incentive Plan. One-third of the stock options become exercisable on the first, second, and third anniversaries of February 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an annual option grant under the TuHURA Biosciences, Inc. 2024 Equity Incentive Plan. One-third of the stock options become exercisable on the first, second, and third anniversaries of February 12, 2026."}],"balance_after":156240,"derivative":{"exercise_price":1.29,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":156240},"source":{"system":"sec-edgar","filing":"0000897069-26-000369","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2061924/000089706926000369/form4.xml","form_type":"4"}},{"id":1197427,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":20016,"kind":"person","name":"Tendler Craig","position":1,"cik":"0002061924","reported_name":"Tendler Craig","relationship":{"director":true}}],"security":"Options (Right to Buy)","published_at":"2025-03-19T23:13:50.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":151883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the stock options become exercisable on the first, second, and third anniversary of March 10, 2025."}],"balance_after":151883,"derivative":{"exercise_price":1.88,"expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":151883},"source":{"system":"sec-edgar","filing":"0000897069-25-000664","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2061924/000089706925000664/form4.xml","form_type":"4"}}]}